Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis

被引:5
作者
Block, Geoffrey A. [1 ]
Yusuf, Akeem A. [2 ]
Danese, Mark D. [3 ]
Wirtz, Heidi S. [4 ]
Hu, Yan [2 ]
Do, Thy P. [4 ]
Cooper, Kerry [5 ]
Gilbertson, David T. [2 ]
Bradbury, Brian D. [4 ]
Collins, Allan J. [2 ,6 ]
机构
[1] Denver Nephrol, Denver, CO USA
[2] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, 914 South Eighth St,Suite S4-210, Minneapolis, MN 55404 USA
[3] Outcomes Insights, Westlake Village, CA USA
[4] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA 91320 USA
[5] Amgen Inc, Global Med Org, Thousand Oaks, CA 91320 USA
[6] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA
关键词
Chronic kidney disease-mineral bone disorder; End-stage renal disease; Hemodialysis; BONE DISORDER; VASCULAR CALCIFICATION; PARATHYROIDECTOMY; METABOLISM; SURVIVAL;
D O I
10.1186/s12882-016-0382-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients receiving hemodialysis with values outside of target levels for parathyroid hormone (PTH: 150-600 pg/mL), calcium (Ca: 8.4-10.2 mg/dL), and phosphate (P: 3.5-5.5 mg/dL) are at elevated morbidity and mortality risk. We examined whether patients receiving care in dialysis facilities where greater proportions of patients have at least two values out of target have a higher risk of adverse clinical outcomes. Methods: The study cohort consisted of 39,085 prevalent hemodialysis patients in 1298 DaVita dialysis facilities as of September 1, 2009, followed from January 1, 2010, until an outcome, a censoring event, or December 31, 2010. We determined the quintile of the distribution across facilities of the proportion of patients with at least two of three parameters out of, or above, target over a 4-month baseline period. The primary composite outcome was cardiovascular hospitalization or death. Secondary outcomes included death, cardiovascular hospitalization, and parathyroidectomy. Poisson regression models were used to estimate the association of facility quintile with outcomes. Results: Facility quintile was associated with a 7 % increased risk of cardiovascular hospitalization or death (quintile 5 versus 1, RR 1.07, 95 % CI 1.01-1.13) using the out-of-target measure of exposure and a 12 % increased risk (RR 1.12, 95 % CI 1.06-1.19) using the above-target measure. No association was seen for death using either measure. Patients in facility quintiles 3-5 (versus 1) were at increased parathyroidectomy risk (RR ranged from 2.05, 95 % CI 1.10-3.82, for quintile 3 to 2.73, 95 % CI 1.50-4.98, for quintile 5). Conclusions: Facility level analysis of a large prevalent sample of US patients on hemodialysis demonstrates that patients in facilities with the least control of PTH, Ca, and P had the greatest risk of parathyroidectomy or the combination of cardiovascular hospitalization or death.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 16 条
[1]   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].
Block, GA ;
Klassen, PS ;
Lazarus, JM ;
Ofsthun, N ;
Lowrie, EG ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218
[2]   CKD-Mineral and Bone Disorder and Risk of Death and Cardiovascular Hospitalization in Patients on Hemodialysis [J].
Block, Geoffrey A. ;
Kilpatrick, Ryan D. ;
Lowe, Kimberly A. ;
Wang, Wenli ;
Danese, Mark D. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (12) :2132-2140
[3]   Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study [J].
Brunelli, Steven M. ;
Sibbel, Scott ;
Do, Thy P. ;
Cooper, Kerry ;
Bradbury, Brian D. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (04) :655-665
[4]   Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis [J].
Chertow, Glenn M. ;
Block, Geoffrey A. ;
Correa-Rotter, Ricardo ;
Drueeke, Tilman B. ;
Floege, Juergen ;
Goodman, William G. ;
Herzog, Charles A. ;
Kubo, Yumi ;
London, Gerard M. ;
Mahaffey, Kenneth W. ;
Mix, T. Christian H. ;
Moe, Sharon M. ;
Trotman, Marie-Louise ;
Wheeler, David C. ;
Parfrey, Patrick S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (26) :2482-2494
[5]   Consistent control of mineral and bone disorder in incident hemodialysis patients [J].
Danese, Mark D. ;
Belozeroff, Vasily ;
Smirnakis, Karen ;
Rothman, Kenneth J. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (05) :1423-1429
[6]   Refining the definition of clinically important mineral and bone disorder in hemodialysis patients [J].
Danese, Mark D. ;
Halperin, Marc ;
Lowe, Kimberly A. ;
Bradbury, Brian D. ;
Do, Thy P. ;
Block, Geoffrey A. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (08) :1336-1344
[7]  
Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607
[8]   Clinical Outcomes after Parathyroidectomy in a Nationwide Cohort of Patients on Hemodialysis [J].
Ishani, Areef ;
Liu, Jiannong ;
Wetmore, James B. ;
Lowe, Kimberly A. ;
Do, Thy ;
Bradbury, Brian D. ;
Block, Geoffrey A. ;
Collins, Allan J. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (01) :90-97
[9]   A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients [J].
Kalantar-Zadeh, K ;
Block, G ;
Humphreys, MH ;
McAllister, CJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (02) :442-453
[10]  
Kidney Disease: Improving Global Outcomes (KDIGO) CKD- MBD Work Group, 2009, KIDNEY INT S113, V76, pS1